Bharat Biotech shares Covaxin research data in full, promises final Phase III results soon
- Bharat Biotech stated that Covaxin is the only Covid vaccine to have published data on most emerging variants
- Final analysis data for Covaxin will be submitted to CDSCO first, and then to peer-reviewed journals
Hyderabad-based Bharat Biotech shared complete data of all research studies conducted for Covaxin so far, adding that the final Phase III analysis data will be released soon.
Select your Category
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more